TFO Wealth Partners’s DexCom DXCM Stock Holding History

TFO Wealth Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-16	Closed	-$1K	–	234
2022 Q2	$1K	Buy	+16	New	+$1.46K	﹤0.01%	396

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TFO Wealth Partners's DXCM Position: Q3 2022 in Review

TFO Wealth Partners sold out of DexCom (DXCM) in Q3 2022, closing a stake of 16 shares — an estimated $1K sold.

TFO Wealth Partners first reported a position in DXCM in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

TFO Wealth Partners reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
TFO Wealth Partners sold 16 DexCom shares in Q3 2022, an estimated $1K.
TFO Wealth Partners first reported a position in DexCom in Q2 2022 and held it in 1 quarter.
TFO Wealth Partners's DexCom position peaked at $1K in Q2 2022.
794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on TFO Wealth Partners's 13F filing for Q3 2022, filed 8 Nov 2022.